Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 993-1000

  Hu, Zenan ^a   Liu, Xiaojun ^a   Tang, Zhifeng ^a   Zhou, Yongning ^a   Qiao, Liang ^b  

^a LANZHOU UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

E cadherin; Gastric cancer; NF B; Snail

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ADULT; ARTICLE; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; CADHERINS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NF-KAPPA B; PYRROLIDINES; STOMACH NEOPLASMS; THIOCARBAMATES; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84872787452     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2200     Document Type: Article

References (48)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
3. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005. (Pubitemid 40165308)
4. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20, 2006. (Pubitemid 43126077)
5. Baeuerle PA and Baltimore D: NF-κB: ten years after. Cell 87: 13-20, 1996.
6. Bours V, Dejardin E, Goujon-Letawe F, Merville MP and Castronovo V: The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol 47: 145-149, 1994. (Pubitemid 24045827)
7. Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246, 2001. (Pubitemid 32157954)
8. Frixen UH, Behrens J, Sachs M, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991. (Pubitemid 21909684)
9. Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339, 1998. (Pubitemid 28373643)
10. Gabbert HE, Mueller W, Schneiders A, et al: Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184-189, 1996. (Pubitemid 26233296)
11. Mao Z, Ma X, Rong Y, et al: Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-κB pathway. Cancer Sci 102: 104-110, 2011.
12. Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W and Schlag PM: Immunohistological analysis of E-cadherin, alpha-, beta-and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 35: 60-65, 1999. (Pubitemid 29079492)
13. Pignatelli M, Ansari T W, Gunter P, et al: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174: 243-248, 1994.
14. Oka H, Shiozaki H, Kobayashi K, et al: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993. (Pubitemid 23113254)
15. Zhou Y, Li G, Wu J, et al: Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumour Biol 31: 549-558, 2010.
16. Kyrlagkitsis I and Karamanolis DG: Genes and gastric cancer. Hepatogastroenterology 51: 320-327, 2004. (Pubitemid 38283124)
17. Mimata A, Fukamachi H, Eishi Y and Yuasa Y: Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 102: 942-950, 2011.
18. Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166, 2002.
19. Bonavida B and Baritaki S: Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-κB/Snail/YY1/RKIP circuitry. Nitric Oxide 24: 1-7, 2011.
20. Wu Y and Zhou BP: Snail: more than EMT. Cell Adh Migr 4: 199-203, 2010.
21. Rosivatz E, Becker I, Specht K, et al: Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am J Pathol 161: 1881-1891, 2002. (Pubitemid 35265545)
22. Castro Alves C, Rosivatz E, Schott C, et al: Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 211: 507-515, 2007. (Pubitemid 46502426)
23. Bosman FT: WHO classification of tumours of the digestive system. In: World Health Organization. International Agency for Research on Cancer. 4th edition. IARC Press, Lyon, 2010.
24. Volm M, Koomagi R and Mattern J: Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 74: 64-68, 1997. (Pubitemid 27157857)
25. Vichai V and Kirtikara K: Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1: 1112-1116, 2006.
26. Woolston C and Martin S: Analysis of tumor and endothe-lial cell viability and survival using sulforhodamine B and clonogenic assays. Methods Mol Biol 740: 45-56, 2011.
27. Zhou Y, Ran J, Tang C, et al: Effect of celecoxib on E-cadherin, VEGF, microvessel density and apoptosis in gastric cancer. Cancer Biol Ther 6: 269-275, 2007. (Pubitemid 46641634)
28. Dentice M, Luongo C, Ambrosio R, et al: Beta-catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology 143: 1037-1047, 2012.
29. Solanas G, Porta-de-la-Riva M, Agustí C, et al: E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci 121: 2224-2234, 2008.
30. Sebastian K, Reza F, Christoph C, et al: Time dependency and topography of hepatic NF-κB activation after hemorrhagic shock and resuscitation in mice. Shock 38: 486-492, 2012.
31. Bernardi FC, Felisberto F, Vuolo F, et al: Oxidative damage, inflammation, and toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study. Oxid Med Cell Longev 2012: 636419, 2012.
32. Jiang Z, Wu W and Qian ML: Cellular damage and apoptosis along with changes in NF-kappa B expression were induced with contrast agent enhanced ultrasound in gastric cancer cells and hepatoma cells. Cancer Cell Int 12: 8, 2012.
33. Lee KH and Kim JR: Regulation of HGF-mediated cell proliferation and invasion through NF-κB, JunB, and MMP-9 cascades in stomach cancer cells. Clin Exp Metastasis 29: 263-272, 2012.
34. Li J, Shen L, Lu FR, et al: Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. Acta Pharmacol Sin 33: 242-249, 2012.
35. Uchikado Y, Okumura H, Ishigami S, et al: Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer 14: 41-49, 2011.
36. Maehata Y, Hirahashi M, Aishima S, et al: Significance of dysad-herin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion. Hum Pathol 42: 558-567, 2011.
37. Biswas DK, Shi Q, Baily S, et al: NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101: 10137-10142, 2004. (Pubitemid 38891208)
38. Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-κB in development and progression of human cancer. Virchows Arch 446: 475-482, 2005. (Pubitemid 40884279)
39. Han SS, Yun H, Son DJ, et al: NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma. Mol Cancer 9: 97, 2010.
40. Fang Y, Sun H, Zhai J, et al: Antitumor activity of NF-κB decoy oligodeoxynucleotides in a prostate cancer cell line. Asian Pac J Cancer Prev 12: 2721-2726, 2011.
41. Dhasarathy A, Kajita M and Wade PA: The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol 21: 2907-2918, 2007. (Pubitemid 350223504)
42. Harder JL, Whiteman EL, Pieczynski JN, Liu CJ and Margolis B: Snail destabilizes cell surface Crumbs3a. Traffic 13: 1170-1185, 2012.
43. Becker KF, Rosivatz E, Blechschmidt K, Kremmer E, Sarbia M and Höfler H: Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs 185: 204-212, 2007. (Pubitemid 46956860)
44. Blechschmidt K, Kremmer E, Hollweck R, et al: The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas. Diagn Mol Pathol 16: 222-228, 2007. (Pubitemid 350196980)
45. Spaderna S, Schmalhofer O, Wahlbuhl M, et al: The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68: 537-544, 2008. (Pubitemid 351380082)
46. He H, Chen W, Wang X, et al: Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci 103: 1296-1303, doi: 10.1111/j.1349-7006.2012.02295.x.
47. Bachelder RE, Yoon SO, Franci C, de Herreros AG and Mercurio AM: Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168: 29-33, 2005. (Pubitemid 40111054)
48. Julien S, Puig I, Caretti E, et al: Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesen-chyme transition. Oncogene 26: 7445-7456, 2007. (Pubitemid 350158710)